Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001–2020
- Resource Type
- Article
- Source
- In
The Lancet Regional Health - Western Pacific April 2024 45 - Subject
Primary Research Articles - Language
- ISSN
- 2666-6065